4 Statistics on Colorectal Cancer Screening by State

How do colorectal cancer screening rates vary across the United States?

Advertisement

Here are four statistics on the percentage of adults age 50 to 75 who had a fecal occult blood test within the previous year, sigmoidoscopy within the previous five years and FOBT within the previous three years or a colonoscopy with the previous 10 years, according to the Centers for Disease Control and Prevention Colorectal Cancer Screening Rates (2010) report.

Percentage of adults up-to-date on screening

54.1 to 59.2: Alaska, Arkansas, Idaho, Illinois, Mississippi, Montana, Nevada, New Mexico, North Dakota, Oklahoma, Test, West Virginia and Wyoming

59.3 to 63.5: Alabama, California, Hawaii, Indiana, Iowa, Kansas, Kentucky, Louisiana, Missouri, Nebraska, Ohio and Tennessee

63.6 to 68.9: Arizona, Colorado, Florida, Georgia, New Jersey, North Carolina, Oregon, Pennsylvania, South Carolina, South Dakota, Utah, Virginia and Wisconsin

69 to 75.2: Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Hampshire, New York, Rhode Island, Vermont and Washington

More Articles on Gastroenterology:
5 Gastroenterologists & Colorectal Surgeons on Improving the National Colorectal Cancer Screening Rate
Are Gastroenterologists Embracing Price Transparency?
Dr. Brian Bosworth Named President of New York Society for Gastrointestinal Endoscopy: 5 Things to Know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.